Pharmaceuticals

Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020

  • APA248310
  • 130 Pages
  • June 2015
  • Pharmaceuticals

The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Moreover, increasing awareness of anti-inflammatory biologics and favorable government initiatives in the Asia-Pacific region are expected to drive the market during the analysis period. Factors, such as side effects of anti-inflammatory drugs and uncertain patent legislations, i.e., compulsory licensing in India would continue to impede the market growth.



The Asia-Pacific anti-inflammatory therapeutics market is segmented on the basis of indication, drug class and geography. The indications considered in this report include arthritis, respiratory diseases, multiple sclerosis, psoriasis, inflammatory bowel disease and other inflammatory diseases. Among indications, arthritis was the dominant segment accounting for 41.3% of the APAC anti-inflammatory therapeutics market in 2014 and holds potential for growth during the forecast period. Anti-inflammatory biologics are the most preferred drugs for treatment of arthritis. 



On the basis of drug class, the market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Anti-inflammatory biologics holds the largest share among drug classes accounting for around 50% share of the Asia-Pacific anti-inflammatory therapeutics market, and is expected to grow rapidly during the forecast period. Geographically, the market is segmented into six countries namely Japan, China, India, Australia, South Korea, Indonesia and others. Among these countries, Japan holds the largest share in the Asia-Pacific anti-inflammatory therapeutics market; however, China is expected to exhibit the fastest growth during the forecast period. Major market players have adopted strategies such as collaborations, indication expansions and product launches to expand their market presence. In 2014, Novartis got marketing approval for the drug Cosentyx (secukinumab) in Japan for the treatment of psoriatic arthritis. The company has filed new patents to overcome the issues of patent expiries of their existing drugs and to gain a prominent market share. The key companies profiled in this report are Pfizer, Inc., AbbVie, Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & CO., Inc., Novartis AG, F. Hoffmann-La Roche AG, Eli Lily and Company, AstraZeneca PLC and Amgen.



KEY MARKET BENEFITS




  • The report provides a quantitative analysis of the current market and estimations during 2014‐2020 that assist in identifying and capitalizing on the prevailing market opportunities

  • Exhaustive analysis of the Asia-Pacific anti-inflammatory therapeutics market by product type helps in understanding the types of therapeutics and their categories that are currently being used to gain prominence in future

  • Competitive intelligence of leading manufacturers and distributors of anti-inflammatory therapeutics helps in understanding the competitive scenario across the geographies

  • Comprehensive analysis of factors that drive and restrict the growth of the Asia-Pacific anti-inflammatory therapeutics market has been provided

  • SWOT analysis facilitates the study of internal environment of leading companies for strategic decision-making

  • The country-wise analyses of anti-inflammatory therapeutics market conditions have been provided in this report



KEY MARKET SEGMENTS

The Asia-Pacific Anti-inflammatory Therapeutics Market is segmented below:




  • Asia-Pacific Anti-inflammatory Therapeutics Market - By Indication


    • Arthritis

    • Respiratory diseases

    • Multiple sclerosis

    • Psoriasis

    • Inflammatory bowel disease

    • Other inflammatory diseases






  • Asia-Pacific Anti-inflammatory Therapeutics Market - By Drug Class


    • Anti-Inflammatory Biologics

    • Non-Steroidal Anti-inflammatory drugs (NSAIDs)

    • Corticosteroids






  • Asia-Pacific Anti-inflammatory Therapeutics Market - By Country


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Indonesia

    • Other APAC countries




Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Nephrology and Urology Devices Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013 - 2020)

Nephrology and urology devices are medical devices that are used for the treatment of urinary system and kidney diseases such as chronic kidney diseases (CKD), urinary incontinence and ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Pharmacy Automation Systems Market (Application, End-User and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Pharmacy automation system involves the automation of workflow tasks in the fields of pharmacy or healthcare, such as object counting, prescription management, compound preparation, dispensing, medication packaging and inventory management. ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Smoking Cessation and Nicotine De-Addiction Products Market (Product Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Smoking cessation or nicotine de-addiction involves tobacco discontinuation. Tobacco contains nicotine that causes addiction by releasing the neurotransmitters such as glutamate, dopamine and gamma-aminobutyric acid (GABA). Cigarette and tobacco addicts ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Dilated Cardiomyopathy Asia-Pacific Market Research Report, 2014 - 2020

Dilated cardiomyopathy (DCM) results from heart enlargement. It is a fetal cardiac disorder, where heart walls become weak and heart fails to pump blood efficiently. It could have negative impact ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Pharmaceutical Excipients Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. The ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Cryosurgery Asia-Pacific Market Research Report, 2013 - 2020

Cryosurgery or Cryotherapy is a minimally invasive treatment that subjects the use of extremely cold temperatures to freeze and destroy diseased tissues, largely used in the treatment of cancer. To ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>